Skip to main content
OpenTrials
Completed

NCT Number: NCT06640543

Effect of Kinesiotape Versus Myofascial Release on Postnatal Low Back Pain

This study aims to determine the difference between the effect of kinesiotape and myofascial release in the treatment of postnatal low back pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Back Pain Back Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

20 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Mahmoud Ahmed Mahmoud

Giza, Egypt

About this study

Postpartum back pain may occur in up to 44% of women after childbirth. People who have chronic back pain may have a limited range of motion and/or tenderness upon touch.

Therapeutic KT can benefit a wide variety of musculoskeletal and sports injuries, plus inflammatory conditions. According to the Kinesiotape Method Manual, this traction promotes an elevation of the epidermis and reduces pressure on the mechanoreceptors located below the dermis, thereby reducing nociceptive stimuli and low back pain.

Myofascial release (MFR) is a treatment that uses gentle pressure and stretching to facilitate the release of fascial restrictions caused by accidents, injury, stress, repetitive use, and traumatic or surgical scarring.

Myofascial release is a form of soft tissue therapy used to treat somatic dysfunction and accompanying pain and restriction of motion. This is accomplished by relaxing the contracted muscle, increasing circulation, increasing venous and lymphatic drainage, and stimulating the stretch reflex of muscles and overlying fascia so, reducing low back pain.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Their ages will be ranged from 20 to 35 years old.
  • Their body mass index (BMI) will not exceed 30 kg/m2.
  • Women will be postnatal period by 6-8 weeks.
  • All women will be diagnosed by the physician as postnatal low back pain.

Exclusion criteria

  • Spinal fracture or any other neurological disorders.
  • Lumbar disc herniation or degenerative disc disease
  • Lumbar spinal stenosis from lumbar disc herniation, degenerative joint disease, or spondylolisthesis
  • Women with BMI exceed 30 kg/m2.
  • Patients who have polyneuropathy or other neurological disorders.
  • Skin disease interferes with kinesiotape or myofascial release application.

Treatment and study plan

Kinesiotape

Other

Postnatal women with low back pain will be treated with kinesiotape, three times per week for 4 weeks

Myofascial Release

Other

Postnatal women with low back pain will be treated with myofascial release for 25 minutes three times per week for 4 weeks

Primary outcomes

  1. Pain intensity level

    Time frame: 4 weeks

    The intensity of postnatal low back pain will be assessed using a visual analogue scale (VAS) for all participants in both groups before and after treatment, which is a method of representing subjects' pain on a 10 cm linear scale. A score of 0 means " no pain" and 10 means " very high degree of pain

Secondary outcomes

  1. Lumbar flexion range of motion

    Time frame: 4 weeks

    The modified Schober test will be used to measure the lumbar flexion range of motion (ROM) by using the tape measurement. Each participant will be asked to stand erect with her feet about shoulder-width apart to stabilize the pelvis. Then, the posterior superior iliac spines(PSIS) will be determined by the therapist's both thumbs, and then an ink line will be drawn along the midline of the lumbar spines horizontal to the PSIS to mark the midpoint between the two PSIS. Then tape will be used to identify and mark two points: one is 10 cm superior to the midpoint (A), and another is 5 cm inferior to the midpoint (B). The participant will be instructed to bend forward as much as she can while keeping both knees straight, the new distance between superior and inferior skin marking will be measured in centimeters. The increased distance along the tape due to lumbar flexion is normally about 6-7 cm (less than 5 cm should be considered abnormal).

  2. Lumbar extension range of motion

    Time frame: 4 weeks

    The modified Schober test will be used to measure the lumbar extension range of motion (ROM) by using the tape measurement while the patient is in a standing position. The participant will be instructed to put her hands on her buttocks and bend backward into full lumbar extension and the new distance between the superior and inferior skin markings will be measured in centimeters by the tape measurement. The change in the difference between the marks is used to indicate the amount of lumbar extension. The increased distance along the tape due to the extension of the lumbar spine is normally about 2-3 cm (less than 1cm should be considered abnormal).

  3. Lumbar lateral flexion range of motion

    Time frame: 4 weeks

    The participant will be asked to stand erect with her feet about shoulder-width apart. Both right and left lateral flexion will be measured by the tape as the distance from the tip of the index finger to the floor at maximal comfortable lateral flexion. The participant will be instructed to bend her trunk laterally as much as she can. The normal value of lateral spinal flexion is 16.2-28.0 cm.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Effect of Kinesiotape Versus Myofascial Release on Postnatal Low Back Pain: a Randomised Controlled Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 15, 2024
Registry last updated
Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.